JP4742063B2 - Low sodium processed salt and food using the same - Google Patents
Low sodium processed salt and food using the same Download PDFInfo
- Publication number
- JP4742063B2 JP4742063B2 JP2007077498A JP2007077498A JP4742063B2 JP 4742063 B2 JP4742063 B2 JP 4742063B2 JP 2007077498 A JP2007077498 A JP 2007077498A JP 2007077498 A JP2007077498 A JP 2007077498A JP 4742063 B2 JP4742063 B2 JP 4742063B2
- Authority
- JP
- Japan
- Prior art keywords
- salt
- potassium chloride
- sodium
- average particle
- particle size
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003839 salts Chemical class 0.000 title claims description 87
- 229910052708 sodium Inorganic materials 0.000 title claims description 45
- 239000011734 sodium Substances 0.000 title claims description 45
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title claims description 43
- 235000013305 food Nutrition 0.000 title claims description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 162
- 235000002639 sodium chloride Nutrition 0.000 claims description 117
- 239000002245 particle Substances 0.000 claims description 81
- 235000011164 potassium chloride Nutrition 0.000 claims description 77
- 239000001103 potassium chloride Substances 0.000 claims description 77
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 42
- 239000002994 raw material Substances 0.000 claims description 26
- 239000011780 sodium chloride Substances 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 10
- 238000005469 granulation Methods 0.000 description 38
- 230000003179 granulation Effects 0.000 description 38
- 235000019640 taste Nutrition 0.000 description 35
- 230000000052 comparative effect Effects 0.000 description 34
- 238000000465 moulding Methods 0.000 description 20
- 238000004090 dissolution Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- 235000019658 bitter taste Nutrition 0.000 description 13
- 238000001035 drying Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 235000019600 saltiness Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 235000019643 salty taste Nutrition 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 238000001125 extrusion Methods 0.000 description 7
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000019606 astringent taste Nutrition 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 235000021023 sodium intake Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010304 firing Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000013535 sea water Substances 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 229940049906 glutamate Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 238000013095 identification testing Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 235000011147 magnesium chloride Nutrition 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- -1 organic acid salts Chemical class 0.000 description 2
- KYKNRZGSIGMXFH-ZVGUSBNCSA-M potassium bitartrate Chemical compound [K+].OC(=O)[C@H](O)[C@@H](O)C([O-])=O KYKNRZGSIGMXFH-ZVGUSBNCSA-M 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000015598 salt intake Nutrition 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- WKNMKGVLOWGGOU-UHFFFAOYSA-N 2-aminoacetamide;hydron;chloride Chemical compound Cl.NCC(N)=O WKNMKGVLOWGGOU-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 239000001692 EU approved anti-caking agent Substances 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- SGSLCUJAFQODKF-UHFFFAOYSA-N [NH4+].[Cl-].[Ca] Chemical compound [NH4+].[Cl-].[Ca] SGSLCUJAFQODKF-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 235000019631 acid taste sensations Nutrition 0.000 description 1
- 239000000654 additive Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229960001040 ammonium chloride Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 230000002358 autolytic effect Effects 0.000 description 1
- RGYXQOYMCJMMOB-UHFFFAOYSA-L azanium;magnesium;trichloride Chemical compound [NH4+].[Mg+2].[Cl-].[Cl-].[Cl-] RGYXQOYMCJMMOB-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- BCQFRUIIFOQGFI-LGVAUZIVSA-L dipotassium guanylate Chemical compound [K+].[K+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O BCQFRUIIFOQGFI-LGVAUZIVSA-L 0.000 description 1
- WDRWZVWLVBXVOI-QTNFYWBSSA-L dipotassium;(2s)-2-aminopentanedioate Chemical compound [K+].[K+].[O-]C(=O)[C@@H](N)CCC([O-])=O WDRWZVWLVBXVOI-QTNFYWBSSA-L 0.000 description 1
- DLDSRSUKRMPQKB-IDIVVRGQSA-L dipotassium;[(2r,3s,4r,5r)-3,4-dihydroxy-5-(6-oxo-3h-purin-9-yl)oxolan-2-yl]methyl phosphate Chemical compound [K+].[K+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 DLDSRSUKRMPQKB-IDIVVRGQSA-L 0.000 description 1
- CVOQYKPWIVSMDC-UHFFFAOYSA-L dipotassium;butanedioate Chemical compound [K+].[K+].[O-]C(=O)CCC([O-])=O CVOQYKPWIVSMDC-UHFFFAOYSA-L 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- WPUMTJGUQUYPIV-JIZZDEOASA-L disodium (S)-malate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](O)CC([O-])=O WPUMTJGUQUYPIV-JIZZDEOASA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- PESYCVVSLYSXAK-MERQFXBCSA-N ethyl (2s)-2-amino-3-(1h-indol-3-yl)propanoate;hydrochloride Chemical compound Cl.C1=CC=C2C(C[C@H](N)C(=O)OCC)=CNC2=C1 PESYCVVSLYSXAK-MERQFXBCSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000004337 magnesium citrate Substances 0.000 description 1
- 229960005336 magnesium citrate Drugs 0.000 description 1
- 235000002538 magnesium citrate Nutrition 0.000 description 1
- 229940053326 magnesium salt Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 235000013919 monopotassium glutamate Nutrition 0.000 description 1
- 235000016337 monopotassium tartrate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000009555 plant derived additive Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- GCHCGDFZHOEXMP-UHFFFAOYSA-L potassium adipate Chemical compound [K+].[K+].[O-]C(=O)CCCCC([O-])=O GCHCGDFZHOEXMP-UHFFFAOYSA-L 0.000 description 1
- 239000001608 potassium adipate Substances 0.000 description 1
- 235000011051 potassium adipate Nutrition 0.000 description 1
- WFIZEGIEIOHZCP-UHFFFAOYSA-M potassium formate Chemical compound [K+].[O-]C=O WFIZEGIEIOHZCP-UHFFFAOYSA-M 0.000 description 1
- 229940086065 potassium hydrogentartrate Drugs 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000009862 primary prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000012887 quadratic function Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 230000009863 secondary prevention Effects 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019265 sodium DL-malate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000001394 sodium malate Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- WRZYGPIFICWRCG-OOFFSTKBSA-M sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trih Chemical compound [Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O WRZYGPIFICWRCG-OOFFSTKBSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seasonings (AREA)
Description
本発明は、少ない使用量で塩化ナトリウム(以下、単に「食塩」という)の有する塩味を呈味することのできる加工塩及びそれを用いた低塩性の食品に関する。
また、本発明は、従来の塩化カリウム固有の味を改善して、呈味性が優れ、しかもさらさらして使いやすい低ナトリウム加工塩に関する。
さらに詳しくは、本発明は、塩化カリウムと食塩からなる成形又は造粒体であって、得られた成形又は造粒体の平均粒径が200〜1600μmで、かつ、原料の塩化カリウムの平均粒径が成形又は造粒体の平均粒径の0.30〜0.85倍である低ナトリウム加工塩に関する。
The present invention relates to a processed salt that can taste the salty taste of sodium chloride (hereinafter, simply referred to as “salt”) and a low-salt food using the same.
The present invention also relates to a low sodium processed salt that improves the taste inherent to conventional potassium chloride, is excellent in taste and is easy to use.
More specifically, the present invention is a molded or granulated product comprising potassium chloride and sodium chloride, and the average particle size of the obtained molded or granulated product is 200 to 1600 μm, and the average particle of the raw material potassium chloride The present invention relates to a low sodium processed salt having a diameter of 0.30 to 0.85 times the average particle diameter of the molded or granulated body.
塩味の素として食品に使用されているのは、現在、圧倒的に食塩であるが、食塩の使用は味の面だけではなく、体内の浸透圧や酸−塩基平衡の調節に重要な役割を果たす等、栄養の面でも必要な物質である。
しかし食塩に含まれるナトリウムは、摂取不足ではなく、生活習慣病、特に高血圧とガンの一次予防の目的から、過剰摂取への対策を必要とする栄養素である。そこで、厚生労働省策定[2005年版]日本人の食事摂取基準では、ナトリウム(食塩相当量)の目標量を成人男性で10(g/日)未満、成人女性で8(g/日)未満と定めている。これは平成13年国民栄養調査における食塩摂取量の中央値より、大幅に低い数値である。
Currently, salt is predominantly used in food as a salty element, but the use of salt plays an important role not only in terms of taste but also in regulating the body's osmotic pressure and acid-base balance. It is a necessary substance in terms of nutrition.
However, sodium contained in salt is not a shortage of intake, but is a nutrient that requires measures against overdose for the purpose of primary prevention of lifestyle-related diseases, particularly high blood pressure and cancer. Therefore, the Ministry of Health, Labor and Welfare [2005 edition] sets the target amount of sodium (equivalent salt) to less than 10 (g / day) for adult men and less than 8 (g / day) for adult women according to Japanese dietary intake standards. ing. This is a much lower value than the median salt intake in the 2001 National Nutrition Survey.
また、治療のためにナトリウムの摂取が制限される場合もある。高血圧治療ガイドライン(日本高血圧学会)で食塩摂取量として6(g/日)未満が勧められており、心筋梗塞二次予防ガイドライン(日本循環器学会Circulation Journal 65(Suppl 4) 2001を参考に作成)で10(g/日)未満を推奨している。
食塩の排出が、主に腎臓を通して行なわれるため、腎臓病でも摂取量が制限されることがある。
健康増進法に定める特別用途食品の中で、病者用単一食品に、ナトリウム含量を通常の食品の50%未満に減少させた低ナトリウム食品が分類されている。低ナトリウム食品は、ナトリウム摂取制限を必要とする疾患(高血圧・全身性浮腫疾患(腎臓疾患・心臓疾患など))に適する旨の表示が許容される。
In addition, sodium intake may be restricted for treatment. The recommended hypertension guideline (Japan Hypertension Society) recommends a salt intake of less than 6 (g / day), and is a guideline for secondary prevention of myocardial infarction (created with reference to Circulation Journal 65 (Suppl 4) 2001) The recommended value is less than 10 (g / day).
Because salt is drained primarily through the kidneys, intake may be limited even in kidney disease.
Among special-purpose foods stipulated in the Health Promotion Act, low-sodium foods whose sodium content is reduced to less than 50% of ordinary foods are classified as single foods for the sick. Low-sodium foods are allowed to be labeled as suitable for diseases requiring restriction on sodium intake (hypertension / systemic edema diseases (kidney diseases, heart diseases, etc.)).
従来、ナトリウム使用量を減少させるために、ナトリウムを低減した代替塩類としては、代表的には塩化カリウムが知られるが、それ以外にも数多く成分が単独あるいは組合せで知られている。
例えば、リン酸カリウム、酒石酸水素カリウム、リンゴ酸ナトリウム、アスコルビン酸カルシウムとアスコルビン酸ナトリウム、塩化アンモニウムと乳酸カルシウム、リジンモノ塩酸塩、コハク酸、塩化マグネシウムアンモニウム、塩化カルシウムアンモニウム等の無機塩類や有機酸塩類があるが、不快感なく純粋に塩味(しお味)を味わえるのは塩化ナトリウムのみであり、どの食塩代替塩類も苦み、えぐ味、渋味等の点で味覚に問題があった。
Conventionally, potassium chloride is typically known as an alternative salt with reduced sodium in order to reduce the amount of sodium used, but many other components are known alone or in combination.
For example, inorganic salts and organic acid salts such as potassium phosphate, potassium hydrogen tartrate, sodium malate, calcium ascorbate and sodium ascorbate, ammonium chloride and calcium lactate, lysine monohydrochloride, succinic acid, magnesium ammonium chloride and calcium ammonium chloride However, it is only sodium chloride that can taste a salty taste without any discomfort, and any salt substitutes have a bitter taste, and have a problem in taste in terms of bitterness, astringency, and the like.
カリウムは、ナトリウムと同じアルカリ金属元素であり、イオン化傾向も近く、塩味を示す数少ない物質であるので、塩化カリウムで食塩の一部を代替した組成物が多用されている。塩化カリウムには不快な苦味や渋味があるので、それを解消するために、例えば、塩化カリウムの併用剤として、ギ酸カリウム、クエン酸マグネシウム、コハク酸二カリウム、各種のクエン酸塩、酒石酸塩、グルコン酸塩、アスコルビン酸塩、サイクラミン酸塩、グルタミン酸塩、自己分解酵母、アジピン酸カリウムと酒石酸カリウム、グルタミン酸カリウム、とアジピン酸、とイノシン酸カリウム、グアニル酸カリウムグリシン、L−アラニン、5−イノシン酸ナトリウム、5−リボヌクレオチドナトリウム、グリチルリチン、グリチルリチン酸ナトリウム、甘草エキス、ステビオサイト、ステビアエキス、アスパルテーム等の甘味成分、リンゴ酸やクエン酸等の酸味料、さらにグルタミン酸塩や核酸呈味物質等の旨み料、塩化マグネシウム、粉末固形苦汁、キレート作用を有するアミノ酸、キレート作用を有する有機酸、自己分解酵母と塩化アンモニウムの組合せ、麦芽デキストリン、リン酸二水素ナトリウム、糖アルコール、還元麦芽糖水あめ、酢酸ナトリウムと塩化マグネシウム及び/又は塩化カルシウムの組合せ、乳清ミネラル、苦汁その他のアルカリ金属塩類と乳清ミネラル、乳清ミネラルと蛋白質や蛋白質分解物やアミノ酸や核酸関連物質と酢酸及び/又は酢酸塩、リン酸塩類、アスコルビン酸ナトリウム、グリシンアミド塩酸塩、グリシンエチルエステル塩酸塩、L−トリプトファンエチルエステル塩酸塩、乳類粉、乳清粉、穀物醸造調味料、有機酸のカルシウム又はマグネシウム塩、カラギーナン、米エキス、コンブエキスと呈味成分の組合せ、ジペプチド又はでん粉加水分解物、硫酸マグネシウム、クエン酸ナトリウム、グルコン酸ナトリウム等もあるが、同様に味覚面に問題があった。 Potassium is the same alkali metal element as sodium, has a close ionization tendency, and is a rare substance exhibiting a salty taste. Therefore, a composition in which a part of salt is replaced with potassium chloride is frequently used. Since potassium chloride has unpleasant bitterness and astringency, in order to eliminate it, for example, potassium formate, magnesium citrate, dipotassium succinate, various citrates, tartrate , Gluconate, ascorbate, cyclamate, glutamate, autolytic yeast, potassium adipate and potassium tartrate, potassium glutamate, and adipic acid, potassium inosinate, potassium guanylate glycine, L-alanine, 5- Sodium inosinate, sodium 5-ribonucleotide, glycyrrhizin, sodium glycyrrhizinate, licorice extract, steviosite, stevia extract, aspartame, etc., acidulants such as malic acid and citric acid, glutamate and nucleic acid taste substances Tastes such as magnesium chloride Powdered solid bitter, chelating amino acid, chelating organic acid, autolysis yeast and ammonium chloride combination, malt dextrin, sodium dihydrogen phosphate, sugar alcohol, reduced maltose syrup, sodium acetate and magnesium chloride and / or Or combinations of calcium chloride, whey minerals, bitter juice and other alkali metal salts and whey minerals, whey minerals and proteins, protein degradation products, amino acids and nucleic acid related substances and acetic acid and / or acetates, phosphates, ascorbic acid Sodium, glycinamide hydrochloride, glycine ethyl ester hydrochloride, L-tryptophan ethyl ester hydrochloride, milk powder, whey powder, grain brew seasoning, organic acid calcium or magnesium salt, carrageenan, rice extract, kombu extract and Combination of taste ingredients, dipeptide or starch There are powdered hydrolysates, magnesium sulfate, sodium citrate, sodium gluconate, etc., but there were also problems with the taste.
また、別途、製造方法の違いで塩化カリウムの不快な味を解消することも知られるが、例えば、グリチルリチン又はステビオサイトで塩化カリウムの表面を被覆して可食性有機酸や旨み成分と混合したもの(特許文献1)、塩化カリウムと塩化ナトリウムとバインダーの混合物を顆粒化してなる顆粒化食塩(特許文献2)、呈味改善剤を添加又はコーティングして味覚を改善したもの、塩化カリウムを核としてアミロセルロース類、エステル類、ビニンアミン類等の胃溶性皮膜剤で被覆し、その周りを食塩で被覆したもの(特許文献3)、塩化カリウムを麦芽デキストリンでコーティングしたもの(特許文献4)、塩化カリウム混合水溶液の水分を蒸発させたもの(特許文献5)、塩化カリウム又は塩化カリウムと塩の混合物に有機酸、アミノ酸、可溶性ペプチド、たんぱく質及び糖質の1種以上を添加して水に溶解後、噴霧乾燥したもの(特許文献6)、精製塩を微粉末に粉砕し、これに香辛料とつなぎ物質として片栗粉又は化学調味料やカルシウムを混入したもの、水性塩混合物を瞬間乾燥して塩化ナトリウムとカリウム/マグネシウム複合塩と塩化カリウムを含有したものも同様に呈味性の問題があった。 In addition, it is also known that the unpleasant taste of potassium chloride is eliminated due to the difference in the production method. For example, the surface of potassium chloride is coated with glycyrrhizin or stevite and mixed with edible organic acids and umami ingredients. (Patent Document 1), Granulated salt obtained by granulating a mixture of potassium chloride, sodium chloride and a binder (Patent Document 2), a taste improver by adding or coating a taste improver, and potassium chloride as a core Coated with a gastric soluble coating agent such as amylocelluloses, esters, bininamines, etc., and coated with salt (Patent Document 3), coated with potassium chloride with malt dextrin (Patent Document 4), chloride Evaporated water of potassium mixed aqueous solution (Patent Document 5), potassium chloride or a mixture of potassium chloride and salt with organic acid, amino , One or more of soluble peptides, proteins and carbohydrates, dissolved in water, spray-dried (Patent Document 6), refined salt is pulverized into fine powder, and spices and starch are used as starch or chemical A seasoning and calcium mixed, and an aqueous salt mixture which was instantly dried to contain sodium chloride, a potassium / magnesium composite salt and potassium chloride also had a taste problem.
溶解速度の特に速い食塩を用い、呈味性を改善した低ナトリウム鹹味料も開示されている(特許文献7)が、根本的には食塩と塩化カリウムの味が別々に感じられるもので、塩化カリウムの本来有する苦みを減少せしめるものではなかった。 A low sodium flavoring agent having improved taste by using salt with a particularly high dissolution rate is also disclosed (Patent Document 7), but the taste of salt and potassium chloride is fundamentally felt separately. It did not reduce the original bitterness of potassium.
本発明では、上述するような塩化カリウム特有の不快味を抑制して、少ない食塩量、すなわち低いナトリウム量で塩味がより強く感じられ、しかも、さらさらして使用性の高い低ナトリウム加工塩及びそれを使用した食品を提供することを課題とする。 The present invention suppresses the unpleasant taste peculiar to potassium chloride as described above, and a low sodium processed salt that has a low salt amount, that is, a salty feeling that is strong with a low sodium amount, and that is easy to use. It is an object to provide a food product using the above.
本発明者らは、加工塩を口に含んだ際の粒子径の大きさと口どけと味の関係に着目して、前記課題を解決すべく鋭意研究した結果、塩化カリウムと食塩からなる成形又は造粒体であって、成形又は造粒体の平均粒径が200〜1600μmで、かつ、原料の塩化カリウムの平均粒径が得られた成形又は造粒体の0.30〜0.85倍とすることにより、塩化カリウムの有する不快な味が抑えられることを見出し、本発明を完成するに至った。 The present inventors paid attention to the relationship between the size of the particle diameter when the processed salt is included in the mouth and the mouthfeel and the taste, and as a result of earnest research to solve the above-mentioned problems, A granulated body having an average particle diameter of 200 to 1600 μm, or 0.30 to 0.85 times that of the molded or granulated body having an average particle diameter of the raw material potassium chloride. As a result, it was found that the unpleasant taste of potassium chloride can be suppressed, and the present invention has been completed.
本発明の基本的な構成は、以下のとおりである。
(1)固体状の塩化カリウムと固体状の食塩の成形又は造粒体であって、成形又は造粒体の平均粒径が200〜1600μmで、かつ、原料の固体状塩化カリウムの平均粒径が成形又は造粒体の平均粒径の0.30〜0.85倍であることを特徴とする、低ナトリウム加工塩。
(2)塩化カリウム:食塩の重量比が、(20:80)〜(80:20)であることを特徴とする(1)に記載の低ナトリウム加工塩。
(3)上記(1)又は(2)に記載の低ナトリウム加工塩が固体状で使用されている食品。
The basic configuration of the present invention is as follows.
(1) A molded or granules of solid potassium chloride and solid sodium chloride, the average particle size of the molded or granulated material is in 200~1600Myuemu, and an average particle diameter of the raw material of the solid potassium chloride Is a low sodium processed salt, characterized in that is 0.30 to 0.85 times the average particle size of the molded or granulated body.
(2) The low sodium processed salt according to (1), wherein the weight ratio of potassium chloride: salt is (20:80) to (80:20).
(3) Foods in which the low sodium processed salt according to (1) or (2) is used in a solid state .
本発明では、塩化カリウム:食塩の重量比が、(20:80)〜(80:20)の混合物に、1〜10重量部、好適には4〜8重量部の水分を添加して混練し、粘土状になった後に篩い又はスクリーンで押出し、乾燥、解砕、篩い分けによって目的とする粒子を製造する。
この目的のためには、塩化カリウムと食塩の混合物を粉末、スラリー、溶融液、溶液等から成形又は造粒体とすることができ、転動造粒、振動造粒、圧縮成形造粒、焼結造粒、混合造粒、流動造粒、解砕造粒、押し出し成形造粒、鋳込み成形造粒、フレイカー造粒、噴射造粒、板上滴下造粒、鋳造造粒、流動乾燥造粒、晶析造粒、液相反応造粒、噴霧乾燥造粒等の方法をとることができるが、上記方法に限定するものではない。
成形及び造粒の用語については、「造粒成形操作とは、広い意味では英語のsize enlargementが示しているように、微細な粉体、あるいは液状物質から、ある程度以上の粒度をもった粒子をつくりだす操作全般をいう。」(粉体 理論と応用 改定2版 丸善株式会社)と説明されている。一般的に、「成形」と「造粒」が単独で使用されることを踏まえて、本明細書では「成形又は造粒」と表記する。
In the present invention, 1-10 parts by weight, preferably 4-8 parts by weight of water is added to the mixture of potassium chloride: salt weight ratio (20:80)-(80:20) and kneaded. After becoming a clay, it is extruded through a sieve or a screen, and the desired particles are produced by drying, crushing and sieving.
For this purpose, a mixture of potassium chloride and sodium chloride can be formed or granulated from powders, slurries, melts, solutions, etc., rolling granulation, vibration granulation, compression molding granulation, sintering. Granulation, mixed granulation, fluidized granulation, pulverized granulation, extrusion molding granulation, cast molding granulation, flaker granulation, spray granulation, drop granulation on plate, casting granulation, fluidized drying granulation, Methods such as crystallization granulation, liquid phase reaction granulation, and spray drying granulation can be employed, but the method is not limited to the above methods.
For the terms of molding and granulation, the term “granulation and molding operations in a broad sense refers to the creation of particles with a particle size of a certain level or more from fine powders or liquid substances, as indicated by the English size enlargement. It refers to the overall operation of making. ”(Powder theory and application, revised 2nd edition, Maruzen Co., Ltd.) Generally, “molding” and “granulation” are used in the present specification, because “molding” and “granulation” are used independently.
塩味の効果がより感じられ、塩化カリウムの不快な味を感じにくくするためには、塩化カリウムと食塩からなる成形又は造粒体であって、成形又は造粒体の平均粒径が200〜1600μmかつ、原料の塩化カリウムの平均粒径が、目的物とする成形又は造粒体の平均粒径の0.30〜0.85倍であることが好ましい。また、低ナトリウム加工塩中の塩化カリウム:食塩の重量比は、(20〜80):(80〜20)の範囲、が好ましい。また、成形又は造粒時に若干の水分を含ませることが好ましい態様で、続いて行なう乾燥及び/又は焼成後の水の含量が0.01%〜2%程度であれば、粒子の形状が安定し、さらさらして使いやすい。 In order to make the salty effect more felt and to make it difficult to feel the unpleasant taste of potassium chloride, it is a molded or granulated body composed of potassium chloride and sodium chloride, and the average particle size of the molded or granulated body is 200 to 1600 μm. And it is preferable that the average particle diameter of the potassium chloride of a raw material is 0.30-0.85 times the average particle diameter of the shaping | molding or granulated body made into a target object. The weight ratio of potassium chloride: salt in the low sodium processed salt is preferably in the range of (20-80) :( 80-20). In addition, it is preferable that some moisture is included at the time of molding or granulation. If the water content after subsequent drying and / or firing is about 0.01% to 2%, the shape of the particles is stable. And easy to use.
本発明は、塩化カリウムを含むことでナトリウムの摂取量を制限し、塩化カリウムの不快な味を抑制して、塩辛さが程よく感じられ、さらさらして使いやすい。このような低ナトリウム加工塩の平均粒径は、200μm〜1600μmに限定され、原料となる塩化カリウムは、低ナトリウム加工塩の平均粒径の0.30〜0.85倍の平均粒径のものを使用する。このことにより、口に含んだ際に塩化カリウムの溶け始めが遅れ、塩味が良く感じられる。
口に含んだ直後に食塩が溶け出し、この段階で塩味を感じることとなり、続いて塩化カリウムが溶けて、弱いながらも塩味を補強するが、塩化カリウムの溶解に並行して食塩の溶解が進むため、塩化カリウムの苦味や渋味等の不快な味を感じにくくなる。
本発明では、塩化カリウムを含んでいるにもかかわらず、口に含んだ際に塩化カリウムの不快な味を感ずることなく、少ない使用量でも十分に塩味が感じられ、しかもさらさらとして使いやすい低ナトリウム加工塩が得られた。従って、健康の維持や疾病の治療のためにナトリウム摂取を控えたい方に、好適に使用可能な塩味調味料である。
The present invention limits the intake of sodium by containing potassium chloride, suppresses the unpleasant taste of potassium chloride, feels salty, and is easy to use. The average particle size of such low sodium processed salt is limited to 200 μm to 1600 μm, and the raw material potassium chloride has an average particle size of 0.30 to 0.85 times the average particle size of the low sodium processed salt. Is used. As a result, when it is put in the mouth, the start of dissolution of potassium chloride is delayed, and the salty taste is felt well.
Immediately after it is put in the mouth, the salt melts and you will feel salty at this stage, and then the potassium chloride dissolves, strengthening the saltiness although it is weak, but the dissolution of the salt advances in parallel with the dissolution of potassium chloride Therefore, it becomes difficult to feel an unpleasant taste such as a bitter taste or astringency of potassium chloride.
In the present invention, even though it contains potassium chloride, it does not feel the unpleasant taste of potassium chloride when it is put in the mouth, it is sufficiently salty even with a small amount of use, and it is easy to use even more easily. A processed salt was obtained. Therefore, it is a salty seasoning that can be suitably used for those who want to refrain from taking sodium for health maintenance or disease treatment.
本発明の原料となる塩の由来は、海水、天日塩、天日塩溶解後の再晶析塩、イオン交換塩、岩塩、地下鹹水晶析塩、海洋深層水塩等が好ましいが、特に種類は選ばないし、塩の形態は、乾燥塩、湿塩、立方体塩、球状塩、凝集塩、フレーク塩、トレミー塩、粉砕塩、顆粒塩、成形塩、添加物塩等、特に形態を選ばない。
一方、本発明の原料となる塩化カリウムは、鉱物由来、海水由来、植物由来のもの、食品添加物としての基準に合致したもの等、特に限定されるものではない。
The origin of the salt used as the raw material of the present invention is preferably seawater, solar salt, recrystallized salt after dissolution of solar salt, ion exchange salt, rock salt, underground quartz crystal salt, deep seawater salt, etc. The form of the salt is not particularly limited, such as a dry salt, a wet salt, a cubic salt, a spherical salt, an agglomerated salt, a flake salt, a tremy salt, a pulverized salt, a granular salt, a molded salt, and an additive salt.
On the other hand, the potassium chloride used as the raw material of the present invention is not particularly limited, such as mineral-derived, seawater-derived, plant-derived, and food additives that meet the standards.
原料となる塩化カリウム及び/又は食塩の粒子は、予め粉砕機及び/又は造粒機等で所定範囲に調整しておけばよい。
粉砕は、湿式粉砕でも乾式粉砕でもよく、粉砕機はジョークラッシャー、ジャイレトリークラッシャー、コーンクラッシャー、平滑ロールクラッシャー、歯付きロールクラッシャー、インパクトクラッシャー、ハンマークラッシャー、ロッドミル、ボールミル、震動ロッドミル、震動ボールミル、円盤型ミル、ジェットミル等が好適であるが、特に限定されない。
The potassium chloride and / or salt particles used as the raw material may be adjusted in advance to a predetermined range by a pulverizer and / or a granulator.
The pulverization may be either wet pulverization or dry pulverization. A disk type mill, a jet mill and the like are suitable, but are not particularly limited.
原料の成形又は造粒は、前述した各種の方法をとることができるが、前述した各種の方法に限定するものではない。 The molding or granulation of the raw material can take the various methods described above, but is not limited to the various methods described above.
塩化カリウムと食塩の成形又は造粒体の平均粒径が200〜1600μmかつ、原料の塩化カリウムの平均粒径が、得られた成形又は造粒体の平均粒径の0.30〜0.85倍とする。
塩化カリウムの割合が多すぎると、塩化カリウムの不快な味を抑制する効果が得られにくくなり、塩化カリウムの割合が少なすぎるとナトリウム摂取量の低減効果が低くなるため、塩化カリウム:食塩の重量比が、(20:80)〜(80:20)であることが好ましい。
塩化カリウムと食塩以外の成分を加えて、製品に他の機能を付与してもよい。機能成分としては、結着剤、固結防止剤、栄養強化剤、調味料、スパイス、増量剤、滑沢剤、離型剤その他が挙げられる。これらの成分は、原料に加えてもよく、成形又は造粒時に添加してもよく、成形又は造粒後に混合してもよい。
The average particle size of the molded or granulated body of potassium chloride and salt is 200 to 1600 μm, and the average particle size of the raw material potassium chloride is 0.30 to 0.85 of the average particle size of the obtained molded or granulated body. Double.
If the proportion of potassium chloride is too high, it is difficult to obtain the effect of suppressing the unpleasant taste of potassium chloride, and if the proportion of potassium chloride is too small, the effect of reducing sodium intake is reduced, so the weight of potassium chloride: salt The ratio is preferably (20:80) to (80:20).
Components other than potassium chloride and salt may be added to impart other functions to the product. Examples of functional components include binders, anti-caking agents, nutrient fortifiers, seasonings, spices, extenders, lubricants, mold release agents, and the like. These components may be added to the raw material, may be added during molding or granulation, or may be mixed after molding or granulation.
本発明では、上述するように口に含んだ際の美味しさを向上させるために、塩化カリウムと食塩の成形又は造粒を行なうが、成形又は造粒の前に塩化カリウムと食塩を十分に混合し、前述又はそれ以外の造粒方法で粒状にする。
成形又は造粒された低ナトリウム加工塩の表面には、塩化カリウムと食塩が露出している。このとき塩化カリウムの露出面積は、原料として使用した塩化カリウムの表面積及び配合量に影響される。一般に表面積は粒径の2次関数になる。
この低ナトリウム加工塩を口に入れた際に、舐め始めに溶け出す塩化カリウムの量が少ないため、不快な苦味や渋味は抑えられ、塩味が強く感じられる。その後、塩化カリウムと食塩が並行して溶解するため、塩味が自然に感じられる。特許3046966号のように食塩の粒径と溶解速度の関係を考慮する必要はない。上記特許の鹹味料におけるように食塩の溶解速度を規定するだけでは、塩化カリウムが溶け残り、不快な苦味や渋味が直接的に感じられることとなる。
In the present invention, as described above, potassium chloride and sodium chloride are molded or granulated in order to improve the taste when included in the mouth, but potassium chloride and sodium chloride are sufficiently mixed before molding or granulation. And granulated by the above-mentioned or other granulation methods.
Potassium chloride and salt are exposed on the surface of the molded or granulated low sodium processed salt. At this time, the exposed area of potassium chloride is affected by the surface area and the amount of potassium chloride used as a raw material. In general, the surface area is a quadratic function of the particle size.
When this low sodium processed salt is put in the mouth, the amount of potassium chloride that dissolves at the beginning of licking is small, so unpleasant bitterness and astringency are suppressed, and the salty feel is strong. After that, potassium chloride and salt are dissolved in parallel, so that the salty taste is felt naturally. There is no need to consider the relationship between the particle size of sodium chloride and the dissolution rate as in Japanese Patent No. 3046966. If the dissolution rate of sodium chloride is defined only as in the case of the above-mentioned patent, the potassium chloride remains undissolved and an unpleasant bitterness or astringency is directly felt.
成形又は造粒された低ナトリウム加工塩の平均粒径は200μm〜1600μmの範囲となり、粒子が細かければ急速に強い塩味が感じられ、粒子が大粒であれば口の中でゆっくり溶けてまろやかな塩味となる傾向がある。低ナトリウム加工塩の平均粒径が200〜1600μmであることで、食卓塩の他、各種料理及び/又は食品加工用途に好適である。
成形又は造粒のためにバインダーとしてカルボキシメチルセルロースや可溶性でんぷん等の成分を入れても良いが、入れなくてもよい。より塩辛さを感じさせる低ナトリウム加工塩とするために、入れないほうが好ましい。
Molded or granulated low sodium processed salt has an average particle size in the range of 200 μm to 1600 μm, and if the particles are fine, a strong salty taste is felt quickly, and if the particles are large, it melts slowly in the mouth and is mellow It tends to be salty. When the average particle size of the low sodium processed salt is 200 to 1600 μm, it is suitable for various dishes and / or food processing applications in addition to table salt.
Components such as carboxymethyl cellulose and soluble starch may be added as binders for molding or granulation, but they may not be added. In order to obtain a low sodium processed salt that makes saltiness feel more, it is preferable not to add it.
成形又は造粒直後の粒子が水分を多く含む場合は、水分を減少させて形状を安定させ、さらさらの塩にするために、乾燥及び/又は焼成処理を行なう。乾燥及び/又は焼成処理の設備としては、加熱及び/又は減圧が可能で混合及び/又は払出しのしやすい、陶製及び硝子製及びプラスチック製及び金属製容器を用いた静置乾燥、万能混合乾燥機、リボン式混合乾燥機、真空流動乾燥機、振動流動乾燥機、凍結乾燥機、リボコーン、ロータリーキルン、噴霧乾燥機等が好ましいが、これらに限定されない。
最終的な水分量は0.01%〜2.0%であれば、成形又は造粒された形状が保たれ、流動性が高くなるが、さらに好ましくは、0.01%〜0.5%で、さらさらの性状になる。
When the particles immediately after molding or granulation contain a large amount of moisture, drying and / or firing treatment is performed in order to reduce the moisture, stabilize the shape, and form a smooth salt. As drying and / or firing processing equipment, it can be heated and / or decompressed, and can be mixed and / or discharged easily. It is a stationary drying and universal mixing dryer using ceramic, glass, plastic and metal containers. Ribbon-type mixed dryers, vacuum fluidized dryers, vibratory fluidized dryers, freeze dryers, ribocorns, rotary kilns, spray dryers, and the like are preferred, but not limited thereto.
If the final moisture content is 0.01% to 2.0%, the molded or granulated shape is maintained and the fluidity is increased, but more preferably 0.01% to 0.5%. And it becomes a more smooth property.
以下に本発明の実施例を詳細に説明するが、本発明はこの実施例に限定されるものではない。
実施例及び比較例で使用された原料及び/又は調製された加工塩について、以下の(1)〜(6)の方法により、分析及び/又は評価した。
(1)平均粒径
レーザー回折散乱法の粒度分布測定装置(日機装(株)マイクロトラック粒度分布測定装置 MT3300)を使用した。粒度分布測定装置は、設定された粒径範囲における粒子の出現頻度を測定し、サンプルの全体積を100%として縦軸をとり、横軸を粒径にとったグラフで出現頻度の累積曲線を作成する。50%の横線と累積曲線の交点に対応する粒径を、平均粒径(D50)とした。この装置の適正な測定範囲を外れるサンプル(1mm以上)は、ふるい分け法(財団法人塩事業センター発行 塩試験方法 第2版に準拠)を行なった。ふるい枠の内径寸法が200mmの試験用ふるい(JIS Z 8801)を用いてふるい分けを行い、縦軸にふるい通過分積算%、横軸にふるい目開きをとってデータをプロットし、傾向線を引いた。50%の横線と傾向線の交点に対応する粒径を読み取り、平均粒径(D50)とした。
(2)水分
水分の測定は、サンプルを105℃定置乾燥機(品番:LC−112 TABAI ESPEC CORP製)で恒量になるまで乾燥し、残渣量を塩量で除し、この値に100を乗じて求めた。
(3)塩味、苦味、冷涼感、舌触り、甘味、酸味、辛味
10〜12名の男女をパネラーとし、カップに取り分けたサンプルと対照品を、2点嗜好試験法(センソリー・エバリュエーション,増山・小林,垣内出版)の官能検査により評価を行なった。すなわち、パネラーが口に少量のサンプルを含んで、味や感覚の強い方を選択した。パネラーは、事前に五味の識別テストと濃度差識別テストを行い、一定の基準でパスした人を採用した。パネラー選別のテスト方法及び基準は、古川らの報告(第7回官能検査報文集,日科技連)を参考にした。
対照品の低ナトリウム塩としては、海外で広く販売され、日本で最も古くから流通してきた「モートンライトソルト(減塩しお)」(野村事務所)を使用した。成分は、食塩が49.5%で、同量の塩化カリウムと微量の固結防止剤(リン酸3カルシウム、炭酸マグネシウム)が含まれている。モートンライトソルトは、各成分を単に混合したもので、塩化カリウムの不快味がそのまま感じられるものである。後述する表1では、比較例1と記載した。
データの統計的処理として、2点比較法(両側検定)のための検定表を使用し、5%危険率で有意差の有無を判定した。表1には、5%危険率で有意差があった場合は(「P<5%」)、5%危険率で有意差がない場合は(有意差なし)と記載した。
(4)粒強度
10〜12名の男女をパネラーとし、カップに取り分けたサンプルを、指でつまんだときの粒子の強度について、以下の基準で採点した。
2点:粒子はしっかりしていて、十分強い。
1点:強くつまむと粒子が崩壊する。
0点:粒子が簡単に崩壊する。
得点の合計を人数で除し、1点以上であれば粒強度は良好であり(○)、1点未満であれば強度が不十分である(×)として判定した。
(5)流動性
10〜12名の男女をパネラーとし、カップに取り分けたサンプルを、カップごと手で傾けときの流動性について、以下の基準で採点した。
2点:サラサラと容易に流動する。
1点:まとまりながら流動する。
0点:全体が一体となって流動しにくい。
得点の合計を人数で除し、1点以上であれば流動性は良好であり(○)、1点未満であれば流動性が不十分である(×)として判定した。
(6)溶解特性
25℃の蒸留水90gにサンプル10gを投入して攪拌し、一定時間後の塩化カリウム濃度と食塩濃度を測定し、それぞれが10%及び90%溶解する時間を求め、溶解特性を評価した。
Examples of the present invention will be described in detail below, but the present invention is not limited to these examples.
The raw materials used in Examples and Comparative Examples and / or processed salts prepared were analyzed and / or evaluated by the following methods (1) to (6).
(1) Average particle size A particle size distribution measuring device (Nikkiso Co., Ltd. Microtrac particle size distribution measuring device MT3300) of laser diffraction scattering method was used. The particle size distribution measuring device measures the frequency of appearance of particles in the set particle size range, takes the total volume of the sample as 100%, takes the vertical axis, and shows the cumulative frequency of occurrence in a graph with the horizontal axis as the particle size. create. The particle size corresponding to the intersection of the 50% horizontal line and the cumulative curve was taken as the average particle size (D50). Samples (1 mm or more) outside the proper measurement range of this device were subjected to the screening method (based on the salt test method second edition issued by the Salt Business Center). Screening is performed using a test sieve (JIS Z 8801) with an inner diameter of the sieve frame of 200 mm, plotting the data with the vertical axis representing the sieve passing total% and the horizontal axis representing the sieve opening, and drawing a trend line It was. The particle size corresponding to the intersection of the 50% horizontal line and the trend line was read and taken as the average particle size (D50).
(2) Moisture Moisture was measured by drying the sample with a 105 ° C stationary drier (product number: LC-112 TABAI ESPEC CORP) until it became a constant weight, dividing the amount of residue by the amount of salt, and multiplying this value by 100. Asked.
(3) Saltiness, bitterness, coolness, texture, sweetness, sourness, pungent taste 10 to 12 men and women are panelists, and the sample and the control product are divided into two cups (Sensory Evaluation, Masuyama, Evaluation was performed by sensory test by Kobayashi and Kakiuchi Publishing. That is, the panelist included a small amount of sample in his mouth and selected the one with a strong taste and sense. The panelists conducted the Gomi identification test and the density difference identification test in advance, and hired people who passed the standard. The panel selection test method and criteria were based on the report by Furukawa et al.
As a low sodium salt as a control product, “Morton Light Salt” (Nomura Office), which has been widely sold overseas and has been distributed for the longest time in Japan, was used. The component is 49.5% of sodium chloride and contains the same amount of potassium chloride and a small amount of anti-caking agent (tricalcium phosphate, magnesium carbonate). Moreton Light Salt is a simple mixture of each component, and the unpleasant taste of potassium chloride is felt as it is. In Table 1 described later, it is described as Comparative Example 1.
As statistical processing of data, a test table for a two-point comparison method (two-sided test) was used, and the presence or absence of a significant difference was determined at a 5% risk rate. In Table 1, when there was a significant difference at the 5% risk rate (“P <5%”), and when there was no significant difference at the 5% risk rate, it was described as “no significant difference”.
(4) Grain strength 10 to 12 men and women were panelists, and the samples separated into cups were scored according to the following criteria for the strength of the particles when pinched with fingers.
2 points: The particles are solid and strong enough.
1 point: Particles collapse when pinched strongly.
0 point: Particles collapse easily.
The total score was divided by the number of people, and if it was 1 point or more, the grain strength was good (◯), and if it was less than 1 point, the strength was judged as insufficient (x).
(5) Fluidity 10-12 men and women were panelists, and the samples separated into cups were scored according to the following criteria for fluidity when the cups were tilted by hand.
2 points: Easily flows smoothly.
1 point: It flows while being united.
0 point: It is difficult for the whole to flow together.
The total score was divided by the number of people, and if it was 1 or more, the fluidity was good (◯), and if it was less than 1, the fluidity was judged to be insufficient (x).
(6) Dissolution characteristics 10 g of sample was added to 90 g of distilled water at 25 ° C., stirred, potassium chloride concentration and salt concentration were measured after a certain period of time, and the time required for 10% and 90% dissolution of each was obtained. Evaluated.
各原料を表1に示す割合で混合し、表1に示す方法で成形又は造粒してサンプルを作製した。成形又は造粒方法欄の(押出)は、原料に4〜8重量部の水分を添加し、混練して粘土状になった後に篩又はスクリーンから押出し成形又は造粒し、80℃で24時間乾燥させ、解砕及び/又は篩分けで粒度を調整する製造方法を示す。
成形又は造粒方法欄の(転動)は、原料に4〜8重量部の水分を添加し、混練して粘土状になった後に、回転体の中で転動させながら乾燥させて造粒し、篩分けで粒度を調整する製造方法を示す。得られたサンプルを用いて上記試験方法(1)〜(6)により評価した。
(1)〜(5)の結果を表1に、(6)の結果を表2に示す。
Each raw material was mixed at a ratio shown in Table 1, and molded or granulated by the method shown in Table 1 to prepare a sample. In the molding or granulation method column (extrusion), 4 to 8 parts by weight of water is added to the raw material, and after kneading to form a clay, it is extruded or granulated from a sieve or screen, and then at 80 ° C. for 24 hours. The production method of adjusting the particle size by drying and crushing and / or sieving is shown.
(Rolling) in the column of molding or granulation method includes adding 4 to 8 parts by weight of water to the raw material, kneading to form a clay, and then drying while rolling in a rotating body to granulate And a production method for adjusting the particle size by sieving. The obtained samples were used for evaluation by the test methods (1) to (6).
The results of (1) to (5) are shown in Table 1, and the result of (6) is shown in Table 2.
〔表1の結果〕
(1)実施例1は、塩化カリウムと食塩を成形又は造粒して作製した低ナトリウム加工塩で、成形又は造粒されていない比較例1(モートンライトソルト)と比べて、危険率Pが5%未満の確率で、有意に塩味と舌触りが強く、苦味と冷涼感が弱かった。実施例1と同じ原料を用いて、混合のみ行い、成形又は造粒しなかった比較例2は、比較例1と比べて有意な差はなかった。よって、成形又は造粒することが、本発明による味の改善の要件である。
(2)実施例2で、平均粒径が460μmの大きな粒の食塩を原料に使用し、成形又は造粒して低ナトリウム加工塩を作製した。実施例1と同様に、比較例1より有意に塩味と舌触りが強く、苦味と冷涼感が弱かった。一方、実施例2と同じ原料を使用し、混合のみ行い、成形及び造粒しなかった比較例3は、比較例1と比べて有意な差はなかった。このことより、原料の食塩の平均粒径は味への影響が少ないと推定された。
(3)実施例3は平均粒径が200μm、実施例4は平均粒径が1600μmだったが、共に試作が可能で、官能検査において比較例1より有意に塩味と舌触りが強く、苦味と冷涼感が弱かった。一方、比較例4で平均粒径を150μmにするため試作を行なったが、スクリーンからの押出し成形が困難だった。解砕造粒等と組合せての粒度調整も可能であるが、コスト高となる。また、平均粒径2000μmの比較例5を評価したところ、粒強度が低かった。よって、最終的な低ナトリウム加工塩の平均粒径は本発明の要件であり、200μm〜1600μmの範囲が適当である。
(4)実施例5及び6では、低ナトリウム加工塩の平均粒径を200μmとし、実施例5では平均粒径が60μm(200μmに対して0.30倍)、実施例6では平均粒径が170μm(200μmに対して0.85倍)である塩化カリウムを原料に使用して試作を行なった。実施例5及び6は試作が可能で、官能検査において比較例1に比べ有意に塩味と舌触りが強く、苦味と冷涼感が弱かった。比較例6及び7では、低ナトリウム加工塩の平均粒径を200μmとし、比較例6では平均粒径が50μm(200μmに対して0.25倍)、比較例7では平均粒径が180μm(200μmに対して0.90倍)である塩化カリウムを原料に使用して試作を行なった。比較例6は試作が可能だったが、官能検査において比較例1と舌触り以外の有意差はなく、目的の効果はなかった。比較例7は、スクリーンからの押出し成形が困難で、他の造粒方法と組合せての粒度調整も可能性があるが、コスト高となる。
実施例7及び8では、低ナトリウム加工塩の平均粒径を1600μmとし、実施例7では平均粒径が480μm(1600μmに対して0.30倍)、実施例8では平均粒径が1360μm(1600μmに対して0.85倍)である塩化カリウムを原料に使用して試作を行なった。実施例7及び8は試作が可能で、官能検査において比較例1と比べて有意に塩味と舌触りが強く、苦味と冷涼感が弱かった。比較例8及び9では、低ナトリウム加工塩の平均粒径を1600μmとし、比較例8では平均粒径が400μm(1600μmに対して0.25倍)、比較例9では平均粒径が1440μm(1600μmに対して0.90倍)である塩化カリウムを原料に使用して試作を行なった。比較例8は試作が可能だったが、官能検査において比較例1と舌触り以外の有意差はなく、目的の効果はなかった。比較例9は、スクリーンからの押出し成形が困難で、他の造粒方法と組合せての粒度調整も可能性があるが、コスト高が見込まれた。
以上をまとめると、塩化カリウムの平均粒径の低ナトリウム加工塩の平均粒径に対する比は、本発明の要件であり、0.30倍〜0.85倍の範囲が適当である。
(5)実施例9は塩化カリウム:食塩の重量比が20:80で、実施例10は塩化カリウム:食塩の重量比が80:20で、共に試作が可能で、官能検査において比較例1と比べて有意に塩味と舌触りが強く、苦味と冷涼感が弱かった。一方、比較例10は塩化カリウム:食塩の重量比が10:90であり、ナトリウムは食塩の90%も含まれている。減塩による各種効果を目的とするには、ナトリウムの割合が高く、食塩と差別化が困難と考えられた。比較例11を官能評価したところ、比較例1と舌触り以外の有意差はなく、目的の効果はなかった。塩化カリウムの配合量が90%であり、食塩の塩味が弱すぎて塩化カリウムの不快な味を抑えられなかった。
以上をまとめると、塩化カリウム:食塩の重量比は、本発明の要件であり、(20:80)〜(80:20)の範囲が適当である。
(6)実施例10では、転動造粒方式で成形又は造粒を行なったが、押出し造粒方式と同様、比較例1に対して味の改善効果があった。
(7)比較例12では乾燥が不十分で、水分が2.3%残っており、流動性が悪い上に粒子が簡単に崩壊した。
[Results of Table 1]
(1) Example 1 is a low sodium processed salt produced by molding or granulating potassium chloride and sodium chloride, and has a risk factor P as compared to Comparative Example 1 (Morton Light Salt) which is not molded or granulated. With a probability of less than 5%, the saltiness and touch were significantly strong, and the bitterness and coolness were weak. Comparative Example 2 in which only the mixing was performed using the same raw materials as in Example 1 and was not molded or granulated was not significantly different from Comparative Example 1. Therefore, shaping or granulating is a requirement for taste improvement according to the present invention.
(2) In Example 2, a large sodium chloride having an average particle diameter of 460 μm was used as a raw material, and a low sodium processed salt was produced by molding or granulating. Similar to Example 1, saltiness and touch were significantly stronger than those of Comparative Example 1, and bitterness and coolness were weaker. On the other hand, Comparative Example 3 using the same raw materials as in Example 2, performing only mixing, and not forming and granulating did not have a significant difference compared with Comparative Example 1. From this, it was estimated that the average particle diameter of the salt of the raw material has little influence on the taste.
(3) Example 3 had an average particle size of 200 μm and Example 4 had an average particle size of 1600 μm. Both samples could be prototyped, and the sensory test was significantly stronger in saltiness and touch than Comparative Example 1, and bitter and cool. The feeling was weak. On the other hand, trial manufacture was performed in order to set the average particle size to 150 μm in Comparative Example 4, but extrusion molding from a screen was difficult. The particle size can be adjusted in combination with pulverized granulation or the like, but the cost is increased. Further, when Comparative Example 5 having an average particle diameter of 2000 μm was evaluated, the grain strength was low. Therefore, the average particle size of the final low sodium processed salt is a requirement of the present invention, and a range of 200 μm to 1600 μm is appropriate.
(4) In Examples 5 and 6, the average particle size of the low sodium processed salt is 200 μm, in Example 5, the average particle size is 60 μm (0.30 times 200 μm), and in Example 6, the average particle size is A prototype was made using potassium chloride of 170 μm (0.85 times as large as 200 μm) as a raw material. Examples 5 and 6 could be prototyped, and the sensory test showed significantly stronger saltiness and touch than Comparative Example 1, and less bitterness and coolness. In Comparative Examples 6 and 7, the average particle size of the low sodium processed salt is 200 μm, in Comparative Example 6, the average particle size is 50 μm (0.25 times as large as 200 μm), and in Comparative Example 7, the average particle size is 180 μm (200 μm). A prototype was made using potassium chloride as a raw material. Although Comparative Example 6 could be prototyped, there was no significant difference in sensory test other than Comparative Example 1 and touch, and there was no desired effect. In Comparative Example 7, extrusion molding from a screen is difficult, and there is a possibility of adjusting the particle size in combination with other granulation methods, but the cost becomes high.
In Examples 7 and 8, the average particle size of the low sodium processed salt is 1600 μm, in Example 7, the average particle size is 480 μm (0.30 times as large as 1600 μm), and in Example 8, the average particle size is 1360 μm (1600 μm). A prototype was made using potassium chloride as a raw material. Examples 7 and 8 were able to be prototyped, and the sensory test showed significantly stronger saltiness and touch than Comparative Example 1, and less bitterness and coolness. In Comparative Examples 8 and 9, the average particle size of the low sodium processed salt was 1600 μm, in Comparative Example 8, the average particle size was 400 μm (0.25 times as large as 1600 μm), and in Comparative Example 9, the average particle size was 1440 μm (1600 μm). A prototype was made using potassium chloride as a raw material. Although Comparative Example 8 was able to be prototyped, there was no significant difference in sensory test other than Comparative Example 1 and touch, and there was no desired effect. Comparative Example 9 was difficult to extrude from a screen and could be adjusted in combination with other granulation methods, but it was expected to be expensive.
In summary, the ratio of the average particle diameter of potassium chloride to the average particle diameter of the low sodium processed salt is a requirement of the present invention, and a range of 0.30 times to 0.85 times is appropriate.
(5) In Example 9, the weight ratio of potassium chloride: salt is 20:80, and in Example 10, the weight ratio of potassium chloride: salt is 80:20. Compared with it, the saltiness and touch were significantly strong, and the bitterness and coolness were weak. On the other hand, in Comparative Example 10, the weight ratio of potassium chloride: salt is 10:90, and sodium contains 90% of the salt. In order to aim at various effects by salt reduction, the ratio of sodium was high, and it was considered difficult to differentiate from salt. As a result of sensory evaluation of Comparative Example 11, there was no significant difference from Comparative Example 1 except for touch, and there was no desired effect. The blending amount of potassium chloride was 90%, and the salty taste of salt was too weak to suppress the unpleasant taste of potassium chloride.
In summary, the weight ratio of potassium chloride: salt is a requirement of the present invention, and a range of (20:80) to (80:20) is appropriate.
(6) In Example 10, molding or granulation was performed by the rolling granulation method, but there was a taste improving effect with respect to Comparative Example 1 as in the extrusion granulation method.
(7) In Comparative Example 12, drying was insufficient and 2.3% of water remained, the fluidity was poor and the particles were easily disintegrated.
〔表2の結果〕
(1)実施例1は、成形又は造粒されていない比較例1及び2と比べて、溶解時間が長いことがわかる。溶解時間の長期化は、成形又は造粒によって水と接触する表面積が減少することで起こる。このことが、塩辛すぎず、まろやかな塩味となる要因と推定された。
(2)実施例1と比較例2は、塩化カリウムより食塩の10%溶解時間が大幅に短い。このことは、粒径の大きな塩化カリウムを使用したことに起因するが、結果として、口に入れた直後に塩味を強く感じる。従って、塩化カリウムの不快な味を感じにくくなると推定される。
(3)比較例2は、食塩よりも塩化カリウムの90%溶解時間が大幅に長い。口に含んで食塩が先に溶け、後で塩化カリウムのみの味を感じることになる。一方、実施例1と比較例1では、塩化カリウムと食塩の90%溶解時間が近いため、塩化カリウムの不快な後味を強く感じることがない。
(4)(1)より、大きく成形又は造粒された低ナトリウム加工塩は、溶解時間が長くなる。(2)と(3)より、塩化カリウムの粒径を適切に調整することで、口に入れた直後からなめ終るまで、塩化カリウムの不快な味を感じるにくくなる。以上の効用を得られることが、示された。
[Results in Table 2]
(1) It can be seen that Example 1 has a longer dissolution time than Comparative Examples 1 and 2 that were not molded or granulated. Longer dissolution time occurs by reducing the surface area in contact with water by molding or granulation. It was estimated that this was not too salty and had a mild salty taste.
(2) In Example 1 and Comparative Example 2, the 10% dissolution time of sodium chloride is significantly shorter than that of potassium chloride. This is due to the use of potassium chloride having a large particle size, but as a result, it feels strongly salty immediately after being put in the mouth. Therefore, it is estimated that it becomes difficult to feel the unpleasant taste of potassium chloride.
(3) In Comparative Example 2, the 90% dissolution time of potassium chloride is significantly longer than salt. Salt in the mouth dissolves first, and later you will feel the taste of potassium chloride only. On the other hand, in Example 1 and Comparative Example 1, since the 90% dissolution time of potassium chloride and sodium chloride is close, the unpleasant aftertaste of potassium chloride is not strongly felt.
(4) From (1), the low sodium processed salt that has been molded or granulated larger has a longer dissolution time. From (2) and (3), by adjusting the particle size of potassium chloride appropriately, it becomes difficult to feel the unpleasant taste of potassium chloride immediately after putting it in the mouth until it is finished licking. It was shown that the above utility can be obtained.
〔総括〕
(1)溶解時間の比較より、塩化カリウムと食塩を成形又は造粒した低ナトリウム加工塩にすることで、口の中での挙動が変わり、味を良くした。低ナトリウム加工塩の平均粒径が200μmを下回ると押出しによる成形又は造粒が困難で、平均粒径が1600μmを超えると、粒強度が低くなる。また、原料の塩化カリウムの平均粒径が低ナトリウム加工塩の平均粒径の0.85倍を超えると押出しが困難になり、0.30倍を下回ると味の改善効果が低くなる。
(2)塩化カリウムと食塩の重量比が(20:80)よりも塩化カリウムの割合が少なくなると、ナトリウム摂取量低減の目的に適さず、(80:20)よりも塩化カリウムの割合が多くなると、塩化カリウムの不快な味が抑えられない。
[Summary]
(1) From the comparison of dissolution time, the behavior in the mouth was changed and the taste was improved by using low sodium processed salt obtained by molding or granulating potassium chloride and salt. When the average particle size of the low sodium processed salt is less than 200 μm, it is difficult to form or granulate by extrusion, and when the average particle size exceeds 1600 μm, the particle strength is lowered. Moreover, if the average particle size of the raw material potassium chloride exceeds 0.85 times the average particle size of the low sodium processed salt, extrusion becomes difficult, and if it is less than 0.30 times, the effect of improving the taste becomes low.
(2) If the weight ratio of potassium chloride and sodium chloride is less than (20:80), it is not suitable for the purpose of reducing sodium intake, and the proportion of potassium chloride is higher than (80:20). , The unpleasant taste of potassium chloride can not be suppressed.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007077498A JP4742063B2 (en) | 2007-03-23 | 2007-03-23 | Low sodium processed salt and food using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007077498A JP4742063B2 (en) | 2007-03-23 | 2007-03-23 | Low sodium processed salt and food using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008228715A JP2008228715A (en) | 2008-10-02 |
JP4742063B2 true JP4742063B2 (en) | 2011-08-10 |
Family
ID=39902282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007077498A Active JP4742063B2 (en) | 2007-03-23 | 2007-03-23 | Low sodium processed salt and food using the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4742063B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5180880B2 (en) * | 2009-03-06 | 2013-04-10 | マナック株式会社 | Salty seasoning and method for producing the same |
BRPI1006571A2 (en) * | 2009-04-29 | 2016-08-23 | Akzo Nobel Chemicals Int Bv | process for preparing a salt product containing sodium chloride and at least one additive, low sodium salt products, and use of the low sodium salt product |
WO2020218401A1 (en) * | 2019-04-24 | 2020-10-29 | 味の素株式会社 | Solid seasoning |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6015300B2 (en) * | 1982-07-22 | 1985-04-18 | 日本家庭用塩株式会社 | Method for producing colored modified salt |
JPS5966858A (en) * | 1982-10-07 | 1984-04-16 | Nitsuten Sangyo Kk | Granular salt |
JPS627624A (en) * | 1985-07-05 | 1987-01-14 | Meiji Seika Kaisha Ltd | Treatment of potassium chloride |
JPH0576309A (en) * | 1991-09-19 | 1993-03-30 | Takara Shuzo Co Ltd | Saline taste agent powder |
JPH067111A (en) * | 1992-06-23 | 1994-01-18 | Toyama Chem Co Ltd | Salty seasoning having low sodium content |
JP3046966B1 (en) * | 1999-03-18 | 2000-05-29 | 新日本ソルト株式会社 | Low sodium salt |
-
2007
- 2007-03-23 JP JP2007077498A patent/JP4742063B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008228715A (en) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6706304B1 (en) | Granular sweetener | |
EP2429316B1 (en) | Process to prepare a low-sodium salt product, product obtainable thereby and the use thereof | |
JP4824628B2 (en) | Salt substitute, low-salt processed food, and method for producing the same | |
AU2014298262A1 (en) | Method of producing salt composition | |
JP4742063B2 (en) | Low sodium processed salt and food using the same | |
JPH11290024A (en) | Araliaceous ginseng extract composition | |
JP2002218964A (en) | Granulated substance of green-colored juice of kale and method for producing the same | |
JP2019201629A (en) | Solid material | |
US6399132B1 (en) | Sweetener composition | |
JP3374686B2 (en) | Soy protein / cocoa granules | |
JP4603508B2 (en) | Method for producing salty seasoning and salty seasoning | |
JP3213829B2 (en) | Peptide-containing composition with improved quality and method for producing the same | |
JP2001238623A (en) | Seaweed-containing noodle | |
JPS5959173A (en) | Preparation of granule or cube of sweetener | |
JP2959832B2 (en) | Whey mineral granules with high calcium content and process for producing the same | |
JPH11239461A (en) | Instant granular broth food and its production | |
JP3540757B2 (en) | Method for producing low hygroscopic confectionery powder material | |
JPH11225702A (en) | Bitterness reducing food | |
JP2001252055A (en) | Method for producing roux material | |
JP3432499B2 (en) | Mixed method of wheat young leaf powder and wheat young leaf mixed powder | |
JPH07264987A (en) | Manufacture of granular vegetable tea | |
JP2002354986A (en) | Preventing agent for fine powdering of granule, method for preventing fine powdering of granule and method for producing granule having preventive property of fine powdering | |
JPH11103780A (en) | Instant cocoa and its production | |
JP2024072414A (en) | Granular collagen peptide, rapidly precipitating granular collagen peptide, and method for producing granular collagen peptide | |
JP2007006835A (en) | Method for producing granular food composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091007 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20101112 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101124 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110315 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110406 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110426 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110509 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4742063 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140513 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |